Chemokines and dendritic cell traffic

Journal of Clinical Immunology

Volumn 20, Issue 3, 2000, Pages 151-160

  Sozzani, Silvano ^a   Allavena, Paola ^a   Vecchi, Annunciata ^a   Mantovani, Alberto ^a,b  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Chemotaxis; Leukocytes; Receptors; Tumors

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR;

ARTICLE; CHEMOTAXIS; DENDRITIC CELL; DOWN REGULATION; HUMAN; IMMUNOREGULATION; NONHUMAN; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

ANIMALS; CELL ADHESION MOLECULES; CELL DIFFERENTIATION; CELL MOVEMENT; CHEMOKINES; DENDRITIC CELLS; ENDOTHELIUM; HUMANS; LYMPHOID TISSUE; NEOPLASMS;

EID: 0033915422     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006659211340     Document Type: Article

References (119)

1. Dendritic cells: Unique leukocyte populations which control the primary immune response
2. Dendritic cells and the control of immunity
3. Dendritic cells
4. Origin, maturation and antigen presenting function of dendritic cells
5. Mobilizing dendritic cells for tolerance, priming, and chronic inflammation
6. Migration patterns of dendritic leukocytes. Implication for transplantation
7. Rapid dendritic cell recruitment is a hallmark of the acute inflammatory response at mucosal surfaces
8. Dendritic cells are recruited into the airway epithelium during the inflammatory response to a broad spectrum of stimuli
9. A life stage of particle-laden rat dendritic cells in vivo: Their terminal division, active phagocytosis, and translocation from the liver to the draining lymph
10. Endotoxin-mediated dendritic cell release from the intestine - Characterization of released dendritic cells and TNF dependence
11. Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1
12. Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo
13. Chemokines
14. Chemokines - Chemotactic cytokines that mediate inflammation
15. The chemokine system: Redundancy for robust outputs
16. Chemokines
17. Adhesion, transendothelial migration, and reverse transmigration of in vitro cultured dendritic cells
18. Adhesion molecules are up-regulated on dendritic cells isolated from human blood
19. Interaction of dendritic cells with skin endothelium: A new perspective on immunosurveillance
20. In vitro adhesion of human epidermal Langerhans cells to laminin and fibronectin occurs through beta I integrin receptors
21. Cadherins and Langerhans cell immunobiology
22. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells
23. Dendritic cell chemotaxis and transendothelial migration are induced by distinct chemokines and are regulated on maturation
24. Migration of dendritic cells in response to formyl peptides, C5a and a distinct set of chemokines
25. Receptor expression and responsiveness of human dendritic cells to a defined set of CC and CXC chemokines
26. Differential responsiveness to constitutive versus inflammatory chemokines of immature and mature mouse dendritic cells
27. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking
28. Human chemokines: An update
29. Chemokines and lymphocyte biology
30. Chemokines and chemokine receptors during activation and deactivation of monocytes and dendritic cells and in amplification of Th1 versus Th2 responses
31. The role of chemokines in the regulation of dendritic cell trafficking
32. Human monocyte-derived and CD34+ cell-derived dendritic cells express functional receptors for platelet activating factor
33. Human immunodeficiency virus-1 entry into purified blood dendritic cells through CC and CXC chemokine coreceptors
34. Cloning and characterization of a specific receptor for the novel CC chemokine MIP-3 alpha from lung dendritic cells
35. CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3 alpha and is highly expressed in human dendritic cells
36. ChemR23, a putative chemoattractant receptor, is expressed in monocyte-derived dendritic cells and macrophages and is a coreceptor for SIV and some primary HIV-1 strains
37. Macrophage inflammatory protein 3α is involved in the constitutive trafficking of epidermal langerhans cells
38. Beta-Defensins: Linking innate and adaptive immunity through dendritic and T cell CCR6
39. Dendritic cells express multiple chemokine receptors used as coreceptors for HIV entry
40. Human recombinant monocyte chemotactic protein and other C-C chemokines bind and induce directional migration of dendritic cells in vitro
41. Upon dendritic cell activation chemokines and chemokine receptor expression are rapidly regulated for recruitment and maintenance of dendritic cells at the inflammatory site
42. Keratinocyte-derived monocyte chemoattractant protein 1 (MCP-1): Analysis in a transgenic model demonstrates MCP-1 can recruit dendritic and Langerhan's cells to skin
43. The multi-faceted personality of HIV
44. Dendritic cells exposed to human immunodeficiency virus type-1 transmit a vigorous cytopathic infection to CD4+ T cells
45. Efficient interaction of HIV-1 with purified dendritic cells via multiple chemokine coreceptors
46. Immature dendritic cells selectively replicate macrophagetropic (M-tropic) human immunodeficiency virus type 1, while mature cells efficiently transmit both M- and T-Tropic virus to T cells
47. HIV-1 selection by epidermal dendritic cells during transmission across human skin
48. Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: Implication for HIV primary infection
49. New insights into the mobilization and phagocytic activity of dendritic cells
50. Bacterial lipopolysac charide rapidly inhibits expression of C-C chemokine receptors in human monocytes
51. Interleukin-10 increases CCR5 expression and HIV infection in human monocytes
52. Selective inhibition of expression of the chemokine receptor CCR2 in human monocytes by IFN-γ
53. Regulation of CCR2 chemokine receptor mRNA stability
54. Regulation of expression of the human monocyte chemotactic protein-1 receptor (hCCR2) by cytokines
55. Cutting edge: Differential regulation of chemokine receptors during dendritic cell maturation: A model for their trafficking properties
56. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites
57. EBI1/CCR7 is a new member of dendritic cell chemokine receptor that is up-regulated upon maturation
58. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation
59. Granulocyte-colony stimulating factor and lipopolysaccharide regulate the expression of interleukin 8 receptors on polymorphonuclear leukocytes
60. Epstein-Barr vires-induced molecule 1 ligand chemokine is expressed by dendritic cells in lymphoid tissues and strongly attracts naive T cells and activated B cells
61. The chemokine SLC is expressed in T cell areas of lymph nodes and mucosal lymphoid tissues and attracts activated T cells via CCR7
62. Lymphotoxin alpha/beta and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen
63. A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes
64. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization
65. CCR7 coordinates the primary immune response by establishing functional microenviroments in secondary lymphoid organs
66. Human macrophage derived chemokine (MDC) a novel chemoattractant for monocytes, monocyte derived dendritic cells, and natural killer cells
67. Dendritic cells produce macrophage inflammatory protein-1 gamma, a new member of the CC chemokine family
68. A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells
69. TECK: A novel CC chemokine specifically expressed by thymic dendritic cells and potentially involved in T cell development
70. A distinct pattern of cytokine gene expression by human CD83(+) blood dendritic cells
71. Activation of human dendritic cells through CD40 cross-linking
72. Chemokine up-regulation and activated T cell attraction by maturing dendritic cells
73. Chemokine up-regulation and activated T cell attraction by maturing dendritic cells
74. Fractalkine and macrophage-derived chemokine: T cell-attracting chemokines expressed in T cell area dendritic cells
75. Fractalkine, a CX3C chemokine, is expressed by dendritic cells and is up-regulated upon dendritic cell maturation
76. CC chemokine receptors, CCR-1 and CCR-3, are potentially involved in antigen-presenting cell function of human peripheral blood monocyte-derived dendritic cells
77. Tumor-associated macrophages in neoplastic progression: A paradigm for the in vivo function of chemokines
78. T-zone histiocytes in adenocarcinoma of the lung in relation to postoperative prognosis
79. S-100 protein-positive dendritic cells in colorectal adenocarcinomas. Distribution and relation to the clinical prognosis
80. Dendritic/Langerhans cells and prognosis in patients with papillary thyroid carcinomas, Immunocytochemical study of 106 thyroid neoplasms correlated to follow-up data
81. Langerhans cells and prognosis in patients with gastric carcinoma
82. Histiocytes in nasopharyngeal carcinoma in relation to prognosis
83. Peritumoral CD1a-positive dendritic cells are associated with improved survival in patients with tongue carcinoma
84. Tumor-infiltrating dendritic cells in adenocarcinomas of the breast: A study of 143 neoplasms with a correlation to usual prognostic factors and to clinical outcome
85. Detection and localization of Mip 3alpha/LARC/Exodus, a macrophage proinflammatory chemokine, and its CCR6 receptor in human pancreatic cancer
86. Prognostic value of HLA-DR expression and dendritic cell infiltration in gastric cancer
87. Lymph node metastasis and relation to tumor growth potential and local immune response in advanced gastric cancer
88. Roles of Langerhans' cells and T-lymphocytes infiltrating cancer tissues in patients treated by radiation therapy for cervical cancer
89. Infiltration by immunocompetent cells in early stage invasive carcinoma of the uterine cervix: A prognostic study
90. Prognostic significance of p53, bcl-2, vimentin, and S100 protein-positive Langerhans cells in endometrial carcinoma
91. Prognostic significance of accessory cells and lymphocytes in nasopharyngeal carcinoma
92. Distribution of S-100 protein-positive dendritic cells and expression of HLA-DR antigen in transitional cell carcinoma of the urinary bladder in relation to tumour progression and prognosis
93. Human sunlight-induced basal-cell-carcinoma-associated dendritic cells are deficient in T cell co-stimulatory molecules and are impaired as antigen-presenting cells
94. Human renal-cell carcinoma tissue contains dendritic cells
95. Physiology and pathophysiology of dendritic cells
96. S100 positive dendritic cells in human lung tumors associated with cell differentiation and enhanced survival
97. Identification and isolation of CD1a positive putative tumour infiltrating dendritic cells in human breast cancer
98. Immunohistochemical localization of CD1a-positive putative dendritic cells in human breast tumours
99. Papillary carcinoma of the thyroid: Hepatocyte growth factor (HGF) stimulates tumor cell to release chemokines active in recruiting dendritic cells
100. Elevated expression of the CC chemokine regulated on activation normal T cell expressed and secreted (RANTES) in advanced breast carcinoma
101. Inflammatory cells infiltrating human colorectal carcinomas express HLA class II but not B7-1 and B7-2 costimulatory molecules of the T-cell activation
102. CD40 expression in epidermal tumors
103. Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma
104. In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas
105. Eosinophilic granuloma of lymph nodes associated with metastatic papillary carcinoma of the thyroid
106. Langerhans cell histiocytosis of the thyroid: A series of seven cases and a review of the literature
107. Langerhans cell histiocytosis of lymph nodes: Draining a papillary carcinoma of the thyroid
108. Langerhans cell histiocytosis associated with papillary carcinoma of the thyroid. Histopathology 32:
109. Immunization with granulocyte-macrophage colony-stimulating factor-transduced, but not B7-l-transduced, lymphoma cells primes idiotype-specific T cells and generates potent systemic antitumor immunity
110. Antitumor effects of granulocyte-macrophage colony-stimulating factor production by melanoma cells
111. Genetic modification of a carcinoma with the IL-4 gene increases the influx of dendritic cells relative to other cytokines
112. Interleukin 12 gene therapy Of MHC-negative murine melanoma metastases
113. Dendritic cells infiltrating tumors cotransduced with granulocyte/macrophage colony-stimulating factor (GM-CSF) and CD40 ligand genes take up and present endogenous tumor-associated antigens, and prime naive mice for a cytotoxic T lymphocyte response
114. Reduced tumorigenicity and augmented leukocyte infiltration after MCP-3 gene transfer: Perivascular accumulation Of dendritic cells in peritumoral tissue and neutrophil recruitment within the tumor
115. Interleukin-10 prevents dendritic cell accumulation and vaccination with granulocyte-macrophage colony-stimulating factor gene-modified tumor cells
116. Effect of interleukin-10 on dendritic cell maturation and function
117. Interleukin- 10 prevents the generation of dendritic cells from human peripheral blood mononuclear cells cultured with Interleukin-4 and granulocyte/macrophage-colonystimulating factor
118. Interleukin-10 prevents the differentation of monocytes to dendritic cells but promotes their maturation to macrophages
119. Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: Role of interleukin-6 and macrophage colony-stimulating factor